Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEARCA:COM TSE:HBP NYSE:NXG NYSEARCA:SCYB On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOMDirexion Auspice Broad Commodity Strategy ETF$33.15$33.90$27.46▼$35.62$258.57M-0.02162,704 shs127,856 shsHBPHelix BioPharmaC$1.42C$1.72C$0.84▼C$5.40C$108.46M0.4217762,438 shs1,114 shsNXGNXG NextGen Infrastructure Income Fund$58.69+0.0%$57.07$45.05▼$60.84N/AN/A69,679 shs43,741 shsSCYBSchwab High Yield Bond ETF$26.18$26.19$25.70▼$26.78$2.43B0.271.23 million shs1.29 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOMDirexion Auspice Broad Commodity Strategy ETF0.00%+0.27%-3.75%-1.49%+15.79%HBPHelix BioPharma0.00%-10.13%-11.25%-13.94%+54.35%NXGNXG NextGen Infrastructure Income Fund0.00%+2.08%+4.30%+6.41%+20.70%SCYBSchwab High Yield Bond ETF0.00%+0.08%+0.19%+1.43%-0.08%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOMDirexion Auspice Broad Commodity Strategy ETF$33.15$33.90$27.46▼$35.62$258.57M-0.02162,704 shs127,856 shsHBPHelix BioPharmaC$1.42C$1.72C$0.84▼C$5.40C$108.46M0.4217762,438 shs1,114 shsNXGNXG NextGen Infrastructure Income Fund$58.69+0.0%$57.07$45.05▼$60.84N/AN/A69,679 shs43,741 shsSCYBSchwab High Yield Bond ETF$26.18$26.19$25.70▼$26.78$2.43B0.271.23 million shs1.29 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOMDirexion Auspice Broad Commodity Strategy ETF0.00%+0.27%-3.75%-1.49%+15.79%HBPHelix BioPharma0.00%-10.13%-11.25%-13.94%+54.35%NXGNXG NextGen Infrastructure Income Fund0.00%+2.08%+4.30%+6.41%+20.70%SCYBSchwab High Yield Bond ETF0.00%+0.08%+0.19%+1.43%-0.08%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOMDirexion Auspice Broad Commodity Strategy ETF 0.00N/AN/AN/AHBPHelix BioPharma 0.00N/AN/AN/ANXGNXG NextGen Infrastructure Income Fund 0.00N/AN/AN/ASCYBSchwab High Yield Bond ETF 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/AHBPHelix BioPharmaN/AN/AC$0.13 per share11.32C$0.19 per shareN/ANXGNXG NextGen Infrastructure Income Fund$39.42MN/AN/AN/AN/AN/ASCYBSchwab High Yield Bond ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AN/AN/AN/AN/AN/AN/AHBPHelix BioPharma-C$50.55M-C$0.04N/AN/AN/AN/A-21.54%-279.98%N/ANXGNXG NextGen Infrastructure Income FundN/A-$0.24N/AN/AN/AN/AN/AN/AN/ASCYBSchwab High Yield Bond ETFN/AN/A60.28N/AN/AN/AN/AN/AN/ALatest NXG, HBP, SCYB, and COM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/12/2026Q3 2026HBPHelix BioPharmaN/A-C$0.01N/A-C$0.01N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCOMDirexion Auspice Broad Commodity Strategy ETF$0.832.50%N/AN/AN/AHBPHelix BioPharmaN/A1.50%N/AN/AN/ANXGNXG NextGen Infrastructure Income Fund$6.6011.25%N/AN/A N/ASCYBSchwab High Yield Bond ETF$1.806.88%N/AN/AN/ALatest NXG, HBP, SCYB, and COM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/2/2026NXGNXG NextGen Infrastructure Income Fundmonthly$0.6012.18%8/17/20268/17/20268/31/20266/2/2026NXGNXG NextGen Infrastructure Income Fundmonthly$0.6012.18%7/15/20267/15/20267/31/20266/2/2026NXGNXG NextGen Infrastructure Income Fundmonthly$0.6012.56%6/15/20266/15/20266/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOMDirexion Auspice Broad Commodity Strategy ETFN/AN/AN/AHBPHelix BioPharma2.440.451.04NXGNXG NextGen Infrastructure Income FundN/AN/AN/ASCYBSchwab High Yield Bond ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOMDirexion Auspice Broad Commodity Strategy ETFN/AHBPHelix BioPharma0.00%NXGNXG NextGen Infrastructure Income FundN/ASCYBSchwab High Yield Bond ETFN/AInsider OwnershipCompanyInsider OwnershipCOMDirexion Auspice Broad Commodity Strategy ETFN/AHBPHelix BioPharma2.15%NXGNXG NextGen Infrastructure Income FundN/ASCYBSchwab High Yield Bond ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOMDirexion Auspice Broad Commodity Strategy ETFN/A7.80 millionN/ANot OptionableHBPHelix BioPharma976.38 millionN/ANot OptionableNXGNXG NextGen Infrastructure Income FundN/AN/AN/AN/ASCYBSchwab High Yield Bond ETFN/A92.80 millionN/ANot OptionableNXG, HBP, SCYB, and COM HeadlinesRecent News About These CompaniesSCYB My Choice Among High Yield ETFsMay 14, 2026 | seekingalpha.comSchwab high yield bond ETF declares monthly distribution of $0.1449May 1, 2026 | msn.comSchwab High Yield Bond ETF declares monthly distribution of $0.1537April 1, 2026 | msn.comSCYB: Trouble Not Yet Boiling Over In High YieldMarch 1, 2026 | seekingalpha.comSchwab high yield bond ETF declares monthly distribution of $0.1481December 19, 2025 | msn.comHigh-Yield Confidence: Advisors Lean Into Credit in the New YearDecember 15, 2025 | etftrends.comESCYB: Cheapest High-Yield Bond ETF, But Not A Buy Right Now (Rating Downgrade)December 12, 2025 | seekingalpha.comSCYB: An Ultra-Low-Cost High Yield ETF To Harvest Carry In A Stable-Price ScenarioDecember 11, 2025 | seekingalpha.comSchwab High Yield Bond ETF declares monthly distribution of $0.1498October 1, 2025 | msn.comSCYB: An Appealing Low-Cost, High-Yield Bond PortfolioSeptember 29, 2025 | seekingalpha.comCSE Bulletin: Consolidation - Scryb Inc. (SCYB)August 11, 2025 | newsfilecorp.comNSCYB: Passive High Yield ETF From SchwabJuly 16, 2025 | seekingalpha.comSchwab High Yield Bond ETF declares $0.1527 dividendJuly 1, 2025 | msn.com7 Lowest Expense Ratio ETFsJune 10, 2025 | money.usnews.comSCYB: Not The Time For High YieldMay 4, 2025 | seekingalpha.comSchwab High Yield Bond ETF declares $0.1586 dividendMay 2, 2025 | seekingalpha.comSchwab High Yield Bond ETF (SCYB) Dividend HistoryMarch 29, 2025 | nasdaq.comTrend Tracker for (SCYB)February 11, 2025 | news.stocktradersdaily.comN(SCYB) Trading SignalsJanuary 31, 2025 | news.stocktradersdaily.comNThese High-Yield Dividend Stocks Are Looking Better Than Bonds for SafetyJanuary 27, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 2026Eli Lilly Wins Back CVS Health, Reverting Novo's AdvantageBy Leo Miller | June 2, 2026Viasat's Orbiting Profits: Space Force Jackpot?By Jeffrey Neal Johnson | June 14, 2026NXG, HBP, SCYB, and COM Company DescriptionsDirexion Auspice Broad Commodity Strategy ETF NYSEARCA:COM$33.15 0.00 (0.00%) As of 06/18/2026 04:10 PM EasternThe Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.Helix BioPharma TSE:HBPC$1.42 0.00 (0.00%) As of 06/19/2026 03:48 PM EasternHelix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today's hardest-to-treat cancers. The Company's pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today's front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix's next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery. The Company also advances two pre-IND candidates: (i) LEUMUNA¿, an oral immune checkpoint modulator aimed at achieving durable remission in post-transplant leukemia relapse, and (ii) GEMCEDA¿, a first-in-class oral gemcitabine prodrug with bioavailability on a par with IV, designed to expand treatment options for advanced cancers.NXG NextGen Infrastructure Income Fund NYSE:NXG$58.69 +0.01 (+0.02%) Closing price 06/18/2026 03:59 PM EasternExtended Trading$58.69 0.00 (0.00%) As of 06/18/2026 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NXG NextGen Infrastructure Income Fund is a closed ended equity mutual fund launched and managed by Cushing MLP Asset Management, LP. The fund invests in stocks of companies across the energy supply chain spectrum, including upstream, midstream and downstream energy companies, as well as oil and gas services and logistics companies, energy-intensive chemical, metal and industrial and manufacturing companies and engineering and construction companies. NXG NextGen Infrastructure Income Fund was formed in 2012 and is domiciled in the United States.Schwab High Yield Bond ETF NYSEARCA:SCYB$26.18 0.00 (0.00%) As of 06/18/2026 04:10 PM EasternThe Schwab High Yield Bond ETF (SCYB) is an exchange-traded fund that mostly invests in high yield fixed income. The fund tracks an index of USD-denominated high-yield, US corporate bonds, selected and weighted based on market value. SCYB was launched on Jul 11, 2023 and is managed by Charles Schwab. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/15 - 06/19 Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself? Why Kroger’s Pullback Could Be a Gift for Patient Investors Credo Technologies Accelerates AI—Its Stock Price Will Follow Why Rocket Lab’s Nasdaq-100 Moment Could Change the Story Why Palantir’s Google Cloud Deal Could Change the Debate VMware: Broadcom's Second Biggest Business Set to Accelerate Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
